Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Embecta Corp.EMBC · Entity 5950 | Chief Human Resources Officer | August 09, 2026 | August 11, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Embecta Corp.
Report date August 09, 2026 · Filed August 11, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 85,914.87 |
Reported balance
After 2026-08-09 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-08-09 · Tax withholding · Disposed 1,480 · Balance 85,914.87 F1: Represents shares withheld for payment of withholding taxes in connection with the vesting of restricted stock units as previously reported on Table I. F2: The number of shares reported in Column 5 of Table I includes shares received by the reporting person as stock dividends. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares withheld for payment of withholding taxes in connection with the vesting of restricted stock units as previously reported on Table I.
F2: The number of shares reported in Column 5 of Table I includes shares received by the reporting person as stock dividends.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
CANTEL MEDICAL CORP
Report date June 02, 2021 · Filed June 02, 2021
Section 16 reporting ended · disclosed 2021-06-02. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, par value $.10 per shareSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2021-06-02 transaction · row 1
1 source rowRow 1 · 2021-06-02 · Disposition to issuer · Disposed 10,566 · Balance 0 F1: Represents (i) a portion of shares that, at the effective time of the First Merger (as defined in the Agreement and Plan of Merger, as amended and restated on March 1, 2021 (the "Merger Agreement"), by and among Cantel Medical Corp., a Delaware corporation (the "Company"), STERIS plc, an Irish public limited company ("STERIS"), Solar New US Holding Co, LLC and Crystal Merger Sub 1, LLC) (the "Effective Time"), were converted into the right to receive (i)0.33787 ordinary shares, par value $0.001 per share, of STERIS (the "Stock Consideration"), and (ii) $16.93 in cash (the "Cash Consideration" and, together with the Stock Consideration, the "Merger Consideration"). F2: Based on the closing price of ordinary shares of STERIS on June 1, 2021, the last trading day before the Effective Time, the value of the Stock Consideration payable per share of common stock, par value $.10 per share, of the Company ("Company Common Stock") was $63.66, and the value of the Merger Consideration payable per share of Company Common Stock pursuant to the Merger Agreement was $80.59 and (ii) a portion of shares that, at the Effective Time, were converted into STERIS equity awards based on an equity award exchange ratio that is intended to preserve the value of the award immediately before and after the conversion. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents (i) a portion of shares that, at the effective time of the First Merger (as defined in the Agreement and Plan of Merger, as amended and restated on March 1, 2021 (the "Merger Agreement"), by and among Cantel Medical Corp., a Delaware corporation (the "Company"), STERIS plc, an Irish public limited company ("STERIS"), Solar New US Holding Co, LLC and Crystal Merger Sub 1, LLC) (the "Effective Time"), were converted into the right to receive (i)0.33787 ordinary shares, par value $0.001 per share, of STERIS (the "Stock Consideration"), and (ii) $16.93 in cash (the "Cash Consideration" and, together with the Stock Consideration, the "Merger Consideration").
F2: Based on the closing price of ordinary shares of STERIS on June 1, 2021, the last trading day before the Effective Time, the value of the Stock Consideration payable per share of common stock, par value $.10 per share, of the Company ("Company Common Stock") was $63.66, and the value of the Merger Consideration payable per share of Company Common Stock pursuant to the Merger Agreement was $80.59 and (ii) a portion of shares that, at the Effective Time, were converted into STERIS equity awards based on an equity award exchange ratio that is intended to preserve the value of the award immediately before and after the conversion.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 09, 2026 Filed Aug 11, 2026 20:31 UTC | Embecta Corp. EMBC · Entity 5950 | Tax withholdingCommon Stock | 1,480 | $4.42 | $6,541.60 |
DisclosureSEC source: 0000947871-26-000779 · ownership.xml · nonDerivative · entry 1 Casner Jean · CIK 0001771800 · Chief Human Resources Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 85,914.87 F1 · shares: Represents shares withheld for payment of withholding taxes in connection with the vesting of restricted stock units as previously reported on Table I. F2 · balance_after: The number of shares reported in Column 5 of Table I includes shares received by the reporting person as stock dividends. Read SEC document |
| November 26, 2025 Filed Dec 2, 2025 02:29 UTC | Embecta Corp. EMBC · Entity 5950 | Tax withholdingCommon Stock | 3,325 | $12.57 | $41,795.25 |
DisclosureSEC source: 0000947871-25-001052 · ownership.xml · nonDerivative · entry 2 Casner Jean · CIK 0001771800 · Chief Human Resources Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 84,704.646 F2 · shares: Represents shares withheld for payment of withholding taxes in connection with the vesting of restricted stock units as previously reported on Table I. F1 · balance_after: The number of shares reported in Column 5 of Table I includes shares received by the reporting person as stock dividends. Read SEC document |
| November 26, 2025 Filed Dec 2, 2025 02:29 UTC | Embecta Corp. EMBC · Entity 5950 | GrantCommon Stock | 38,783 | $0.00 | $0.00 |
DisclosureSEC source: 0000947871-25-001052 · ownership.xml · nonDerivative · entry 1 Casner Jean · CIK 0001771800 · Chief Human Resources Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 88,029.646 F1 · balance_after: The number of shares reported in Column 5 of Table I includes shares received by the reporting person as stock dividends. Read SEC document |
| August 09, 2025 Filed Aug 11, 2025 21:06 UTC | Embecta Corp. EMBC · Entity 5950 | Tax withholdingCommon Stock | 916 | $12.28 | $11,248.48 |
DisclosureSEC source: 0000947871-25-000735 · ownership.xml · nonDerivative · entry 1 Casner Jean · CIK 0001771800 · Chief Human Resources Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,798.926 F1 · shares: Represents shares withheld for payment of withholding taxes in connection with the vesting of restricted stock units as previously reported on Table I. F2 · balance_after: The number of shares reported in Column 5 of Table I includes shares received by the reporting person as stock dividends. Read SEC document |
| November 26, 2024 Filed Nov 29, 2024 18:18 UTC | Embecta Corp. EMBC · Entity 5950 | Tax withholdingCommon Stock | 1,281 | $18.70 | $23,954.70 |
DisclosureSEC source: 0000947871-24-000964 · ownership.xml · nonDerivative · entry 2 Casner Jean · CIK 0001771800 · Chief Human Resources Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,288.005 F1 · shares: Represents shares withheld for payment of withholding taxes in connection with the vesting of restricted stock units as previously reported on Table I. F2 · balance_after: The number of shares reported in Column 5 of Table I includes shares received by the reporting person as stock dividends. Read SEC document |
| November 26, 2024 Filed Nov 29, 2024 18:18 UTC | Embecta Corp. EMBC · Entity 5950 | GrantCommon Stock | 23,396 | $0.00 | $0.00 |
DisclosureSEC source: 0000947871-24-000964 · ownership.xml · nonDerivative · entry 1 Casner Jean · CIK 0001771800 · Chief Human Resources Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 49,569.005 F2 · balance_after: The number of shares reported in Column 5 of Table I includes shares received by the reporting person as stock dividends. Read SEC document |
| August 09, 2024 Filed Aug 13, 2024 20:23 UTC | Embecta Corp. EMBC · Entity 5950 | Tax withholdingCommon Stock | 916 | $15.39 | $14,097.24 |
DisclosureSEC source: 0000947871-24-000689 · ownership.xml · nonDerivative · entry 1 Casner Jean · CIK 0001771800 · Chief Human Resources Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,000 F1 · shares: Represents shares withheld for payment of withholding taxes in connection with the vesting of restricted stock units as previously reported on Table I. F2 · balance_after: The number of shares reported in Column 5 of Table I includes shares received by the reporting person as stock dividends. Read SEC document |
| November 26, 2023 Filed Nov 29, 2023 01:26 UTC | Embecta Corp. EMBC · Entity 5950 | GrantCommon Stock | 15,152 | $0.00 | $0.00 |
DisclosureSEC source: 0000947871-23-001115 · ownership.xml · nonDerivative · entry 1 Casner Jean · CIK 0001771800 · Chief Human Resources Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,429 Read SEC document |
| August 09, 2023 Filed Aug 9, 2023 20:50 UTC | Embecta Corp. EMBC · Entity 5950 | GrantCommon Stock | 11,277 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-045206 · doc4.xml · nonDerivative · entry 1 Casner Jean · CIK 0001771800 · Chief Human Resources Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,277 Read SEC document |
| June 02, 2021 Filed Jun 2, 2021 17:23 UTC | CANTEL MEDICAL CORP CMD · Entity 138805 | Disposition to issuerCommon Stock, par value $.10 per share | 10,566 | $80.59 | $851,513.94 |
DisclosureSEC source: 0001104659-21-075846 · tm2118222-6_4seq1.xml · nonDerivative · entry 1 Casner Jean · CIK 0001771800 · SVP and CHRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: Represents (i) a portion of shares that, at the effective time of the First Merger (as defined in the Agreement and Plan of Merger, as amended and restated on March 1, 2021 (the "Merger Agreement"), by and among Cantel Medical Corp., a Delaware corporation (the "Company"), STERIS plc, an Irish public limited company ("STERIS"), Solar New US Holding Co, LLC and Crystal Merger Sub 1, LLC) (the "Effective Time"), were converted into the right to receive (i)0.33787 ordinary shares, par value $0.001 per share, of STERIS (the "Stock Consideration"), and (ii) $16.93 in cash (the "Cash Consideration" and, together with the Stock Consideration, the "Merger Consideration"). F2 · kind: Based on the closing price of ordinary shares of STERIS on June 1, 2021, the last trading day before the Effective Time, the value of the Stock Consideration payable per share of common stock, par value $.10 per share, of the Company ("Company Common Stock") was $63.66, and the value of the Merger Consideration payable per share of Company Common Stock pursuant to the Merger Agreement was $80.59 and (ii) a portion of shares that, at the Effective Time, were converted into STERIS equity awards based on an equity award exchange ratio that is intended to preserve the value of the award immediately before and after the conversion. F1 · shares: Represents (i) a portion of shares that, at the effective time of the First Merger (as defined in the Agreement and Plan of Merger, as amended and restated on March 1, 2021 (the "Merger Agreement"), by and among Cantel Medical Corp., a Delaware corporation (the "Company"), STERIS plc, an Irish public limited company ("STERIS"), Solar New US Holding Co, LLC and Crystal Merger Sub 1, LLC) (the "Effective Time"), were converted into the right to receive (i)0.33787 ordinary shares, par value $0.001 per share, of STERIS (the "Stock Consideration"), and (ii) $16.93 in cash (the "Cash Consideration" and, together with the Stock Consideration, the "Merger Consideration"). F2 · shares: Based on the closing price of ordinary shares of STERIS on June 1, 2021, the last trading day before the Effective Time, the value of the Stock Consideration payable per share of common stock, par value $.10 per share, of the Company ("Company Common Stock") was $63.66, and the value of the Merger Consideration payable per share of Company Common Stock pursuant to the Merger Agreement was $80.59 and (ii) a portion of shares that, at the Effective Time, were converted into STERIS equity awards based on an equity award exchange ratio that is intended to preserve the value of the award immediately before and after the conversion. F1 · price: Represents (i) a portion of shares that, at the effective time of the First Merger (as defined in the Agreement and Plan of Merger, as amended and restated on March 1, 2021 (the "Merger Agreement"), by and among Cantel Medical Corp., a Delaware corporation (the "Company"), STERIS plc, an Irish public limited company ("STERIS"), Solar New US Holding Co, LLC and Crystal Merger Sub 1, LLC) (the "Effective Time"), were converted into the right to receive (i)0.33787 ordinary shares, par value $0.001 per share, of STERIS (the "Stock Consideration"), and (ii) $16.93 in cash (the "Cash Consideration" and, together with the Stock Consideration, the "Merger Consideration"). F2 · price: Based on the closing price of ordinary shares of STERIS on June 1, 2021, the last trading day before the Effective Time, the value of the Stock Consideration payable per share of common stock, par value $.10 per share, of the Company ("Company Common Stock") was $63.66, and the value of the Merger Consideration payable per share of Company Common Stock pursuant to the Merger Agreement was $80.59 and (ii) a portion of shares that, at the Effective Time, were converted into STERIS equity awards based on an equity award exchange ratio that is intended to preserve the value of the award immediately before and after the conversion. Read SEC document |
| October 10, 2020 Filed Oct 13, 2020 16:08 UTC | CANTEL MEDICAL CORP CMD · Entity 138805 | Tax withholdingCommon Stock, par value $.10 per share | 424 | $47.36 | $20,080.64 |
DisclosureSEC source: 0000019446-20-000093 · wf-form4_160261969367349.xml · nonDerivative · entry 1 Casner Jean · CIK 0001771800 · SVP and CHRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,566 F1 · shares: This represents shares withheld for taxes attributable to vesting of time-based RSUs that vested on 10/10/2020. Read SEC document |
| October 07, 2020 Filed Oct 9, 2020 14:45 UTC | CANTEL MEDICAL CORP CMD · Entity 138805 | GrantCommon Stock, par value $.10 per share | 7,280 | $0.00 | $0.00 |
DisclosureSEC source: 0000019446-20-000081 · wf-form4_160226914031827.xml · nonDerivative · entry 1 Casner Jean · CIK 0001771800 · SVP and CHRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,990 F1 · shares: This represents time-based Restricted Stock Units granted on 10/7/20 that vest in three equal annual installments commencing on the first anniversary of the grant date. Read SEC document |
| October 10, 2019 Filed Oct 15, 2019 11:17 UTC | CANTEL MEDICAL CORP CMD · Entity 138805 | Tax withholdingCommon Stock, par value $.10 per share | 227 | $68.89 | $15,638.03 |
DisclosureSEC source: 0000019446-19-000058 · edgar.xml · nonDerivative · entry 2 Casner Jean · CIK 0001771800 · SVP and CHRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,710 F2 · shares: This represents shares withheld for taxes attributable to the vesting of RSUs on 10/10/19. Read SEC document |
| October 10, 2019 Filed Oct 15, 2019 11:17 UTC | CANTEL MEDICAL CORP CMD · Entity 138805 | GrantCommon Stock, par valu $.10 per share | 1,885 | $0.00 | $0.00 |
DisclosureSEC source: 0000019446-19-000058 · edgar.xml · nonDerivative · entry 1 Casner Jean · CIK 0001771800 · SVP and CHRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,937 F1 · shares: This represents time-based Restricted Stock Units (RSUs) granted on 10/10/19 that vest in three equal annual installments commencing on the first anniversary of the grant date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.